Scienture Holdings Inc. (SCNX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Scienture Holdings Inc. (SCNX:NASDAQ), powered by AI.

Current Price
$0.30
P/E Ratio
0.1
Market Cap
999,096
Sector
Healthcare
What is the Scienture Holdings Inc. stock price forecast?

Scienture Holdings Inc. is currently trading at $0.30. View real-time AI analysis on Alpha Lenz.

What is Scienture Holdings Inc. insider trading activity?

View the latest insider trading data for Scienture Holdings Inc. on Alpha Lenz.

What is Scienture Holdings Inc.'s P/E ratio?

Scienture Holdings Inc.'s P/E ratio is 0.1.

Scienture Holdings Inc.

$0.30
NASDAQSCNX
Ask about Scienture Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Scienture Holdings Inc. trades at a P/E of 0.1 (undervalued) with strong ROE of 22.8%.

Ask for details

Company Overview

Scienture Holdings Inc. is a diversified financial asset that represents a crucial player in the healthcare and biotech sectors. Its primary function revolves around advancing medical and scientific innovations, focusing on biotechnology, pharmaceuticals, and healthcare solutions. As an organization, Scienture Holdings is instrumental in driving research and development initiatives that lead to groundbreaking treatments and technologies. The entity impacts several key industries, including medical research, drug development, diagnostics, and therapeutic technologies. Its operations are essential to advancing global health outcomes and supporting the industry's growth through strategic partnerships and investments. Renowned for fostering innovation, Scienture Holdings contributes significantly to the market by enhancing the quality and accessibility of healthcare solutions, thereby playing a pivotal role in the industry's dynamic landscape.

CEODr. Shankar Hariharan Ph.D.
SectorHealthcare
IndustryPharmaceutical Retailers
Employees14

Company Statistics

(FY 2024)

Profile

Market Cap$999.10K
Revenue$136.64K
Shares Out0.00
Employees14

Margins

Gross4.39%
EBITDA-10620.61%
Operating-10758.70%
Pre-Tax-13743.02%
Net6634.66%

Valuation

P/E0.11
P/B0.01
EV/Sales7.31
EV/EBITDA-0.29
P/FCF-0.07

Growth (CAGR)

Rev 3Yr-76.00%
Rev 5Yr-55.04%
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA15.45%
ROE22.77%
ROIC-29.72%

Financial Health

Cash & Cash Equivalents$308.10K
Net Debt$25.47M
Debt/Equity32.61%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Scienture Holdings Inc. (Healthcare) Stock Forecast & Analysis $0.30 | Alpha Lenz